Search

Your search keyword '"ADC Therapeutics S.A. -- Forecasts and trends"' showing total 7 results
Start Over Descriptor "ADC Therapeutics S.A. -- Forecasts and trends" Topic biotechnology industry -- forecasts and trends
7 results on '"ADC Therapeutics S.A. -- Forecasts and trends"'

1. Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market size is set to grow by USD 2.24 billion from 2024-2028, Growing geriatric population boost the market, Technavio

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, Gilead Sciences Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Biological products industry -- Forecasts and trends, Patient compliance -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Lymphomas -- Forecasts and trends, Vincristine -- Forecasts and trends -- Market size, Radiotherapy -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: The global diffuse large B-cell lymphoma (DLBCL) therapeutics market size is estimated to grow by USD 2.24 billion from 2024-2028, according [...]

Published
2024

2. Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market size is set to grow by USD 2.24 billion from 2024-2028, Growing geriatric population boost the market, Technavio

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Biological products industry -- Forecasts and trends, Patient compliance -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Lymphomas -- Forecasts and trends, Vincristine -- Forecasts and trends -- Market size, Radiotherapy -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, June 27, 2024 /PRNewswire/ -- The global diffuse large B-cell lymphoma (DLBCL) therapeutics market size is estimated to grow by USD 2.24 billion from 2024-2028, according to Technavio. [...]

Published
2024

3. Acute Lymphocytic Leukemia Market to Accelerate Substantially by 2032, Assesses DelveInsight | Key Companies in the Market - Beam, Pfizer, Genentech, AbbVie, Fate, Roche, Ascentage, Janssen, Jazz, ADC, Kymera, Syndax, ImmunoGen

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Genentech Inc. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Beam Therapeutics Inc. -- Forecasts and trends, Oncology, Experimental -- Forecasts and trends, Biological products industry -- Forecasts and trends, Business -- Research, Patient compliance -- Forecasts and trends, Antineoplastic agents -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Antigens -- Forecasts and trends, Acute lymphocytic leukemia -- Forecasts and trends, Cancer -- Research, Pharmaceutical industry -- Forecasts and trends, Antimitotic agents -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release:= DelveInsight's Acute Lymphocytic Leukemia Market Insights report includes a comprehensive understanding of current treatment practices, acute lymphocytic leukemia [...]

Published
2023

4. Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market Size to Grow by USD 1.79 billion, AbbVie Inc. and Bayer AG Among Key Vendors - Technavio

Subjects
Merck & Company Inc. -- Forecasts and trends, Spectrum Pharmaceuticals Inc. -- Forecasts and trends, ADC Therapeutics S.A. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Non-Hodgkin's lymphomas -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, July 25, 2022 /PRNewswire/ -- DLBCL is a cancer of B-lymphocytes and is the most common type of Non-Hodgkins Lymphoma (NHL) among adults. It is a fast-growing and [...]

Published
2022

5. Relapsed or Refractory Diffuse Large B-cell Lymphoma Markets, 2028

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Relapsed or Refractory Diffuse Large B-cell Lymphoma Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028' report [...]

Published
2021

6. Relapsed or Refractory Diffuse Large B-cell Lymphoma Markets, 2028 - ResearchAndMarkets.com

Subjects
United States. Food and Drug Administration -- Reports, ADC Therapeutics S.A. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Relapsed or Refractory Diffuse Large B-cell Lymphoma Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028' report has been added to ResearchAndMarkets.com's offering. Market players [...]

Published
2021

7. Relapsed or Refractory Diffuse Large B-cell Lymphoma Markets, 2028

Subjects
United States. Food and Drug Administration -- Reports, ADC Therapeutics S.A. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-May 27, 2021-: Relapsed or Refractory Diffuse Large B-cell Lymphoma Markets, 2028 (C)1994-2021 M2 COMMUNICATIONS RDATE:27052021 The 'Relapsed or Refractory Diffuse Large B-cell Lymphoma Market - Size, Share, Outlook, [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results